ClinicalTrials.govpublic full text
Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus
lupus erythematosus, systemic, sle, interleukin-2, il-2, t-lymphocytes, regulatory, treg, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 967938
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.